Compounding Pharmacies (503A vs 503B)
How Cash-Pay TRT Gets Its Testosterone
Evidence grade 4 of 5, Strong. Read how the Atlas grades evidence.
The written rationale for this grade is still being prepared.
- FDA
- Compounded drugs are not FDA-approved; governed by FD&C Act sections 503A and 503B
Reference only. Not medical advice.
What can go wrong
Compounded drugs lack FDA premarket approval and, for 503A pharmacies, are not subject to routine FDA inspection. Quality, sterility, and potency depend heavily on the specific pharmacy. Patients should confirm which pharmacy type fills their prescription and whether the facility has a documented quality record.
This is something to take to a clinician. The Atlas can tell you what is known about compounding pharmacies (503a vs 503b) in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.
Many telehealth TRT clinics fill prescriptions through compounding pharmacies rather than dispensing FDA-approved branded or generic testosterone products. Under FDA descriptions of the Federal Food, Drug, and Cosmetic Act, Section 503A pharmacies compound patient-specific prescriptions under state board of pharmacy oversight and are not routinely FDA-inspected, while Section 503B outsourcing facilities register with the FDA, follow current Good Manufacturing Practice (CGMP), and can produce larger batches. Compounded testosterone is not an FDA-approved drug.
Compounded testosterone is not an FDA-approved product, and that distinction matters.
What people take it for
What it is taken for. Approval, where it exists, covers only some of these.
How it works
Under FDA descriptions, 503A pharmacies are exempt from FDA new-drug approval, CGMP, and certain labeling requirements when compounding based on a valid patient-specific prescription; they are overseen mainly by state pharmacy boards and the FDA neither routinely inspects them nor verifies the quality of their preparations. 503B outsourcing facilities voluntarily register with the FDA, are subject to FDA inspection and CGMP, and may compound without patient-specific prescriptions, but their products are generally intended for administration in a clinical setting. The DEA separately oversees testosterone as a controlled substance regardless of which pharmacy type compounds it.
The distinction marketing blurs
Telehealth ads often say physician-supervised and pharmacy-grade. Compounded testosterone is not the same legal category as an FDA-approved drug: it has not gone through FDA premarket review for safety, efficacy, or manufacturing consistency. According to FDA, compounded preparations carry a higher risk of quality problems than approved drugs. The appeal to clinics is flexibility and cost; the trade-off is the absence of FDA approval and routine inspection for 503A products.
Safety in detail
This intervention involves significant physiological effects and requires evaluation and monitoring by a qualified physician. Self-administration without medical oversight carries documented health risks. Compounded testosterone is not an FDA-approved product.
What people get wrong
Often saidCompounded testosterone is FDA-approved because it comes from a pharmacy
ActuallyCompounded drugs are not FDA-approved. 503A products are overseen mainly by state boards of pharmacy and are not routinely FDA-inspected.
Often saidPharmacy-grade means the same as a brand-name drug
ActuallyPharmacy-grade is a marketing phrase, not a regulatory category equivalent to FDA approval.
Who profits, and who pushes back
Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.
What we do not know
- How consistent is potency across 503A compounders?
- Will FDA tighten oversight of high-volume testosterone compounding tied to telehealth?
- How often are patients told whether their drug is compounded versus FDA-approved?
The market for this
What follows describes how this is bought and sold. It is not a buying guide and it is not an endorsement of any seller.
Compounded TRT typically originates from a partner compounding pharmacy assigned by the telehealth clinic, often varying by state and medication type. Sterility and potency assurance differs between 503A and 503B facilities.
At a glance
- 503A oversight
- Primarily state boards of pharmacy
- 503B oversight
- FDA, under CGMP
- 503A scope
- Patient-specific prescriptions
- 503B scope
- Batch production; for-office administration
- Testosterone schedule
- Schedule III (DEA oversight of the controlled substance)
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Compounding Pharmacies (503A vs 503B). A short entry is not a safe entry.
- Timeline. We have not built the dated record of research and regulatory events.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
Sources
No sources recorded for this entry yet. Nothing on this page can be checked against a citation until that changes, so treat it as a summary awaiting its evidence.